4.5 Review

Determining the optimal radiation-surgery interval (RSI) for oncologic proctectomy following radiotherapy for rectal adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

Standard versus longer interval of radical resection after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A 20-year single-center experience & propensity-score matching

Saule Khamzina et al.

Summary: The interval between neoadjuvant chemoradiotherapy (nCRT) and surgery has been debated for its impact on oncological outcomes and postoperative complications. This study found that performing surgery >8 weeks after nCRT can increase tumor regression, but it does not significantly affect oncological outcomes and postoperative complications compared to surgery conducted at 6-8 weeks after nCRT.

JOURNAL OF SURGICAL ONCOLOGY (2023)

Article Gastroenterology & Hepatology

Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer

Zhaomin Xu et al.

Summary: This study compared the impact of total neoadjuvant therapy with neoadjuvant chemoradiation alone on postoperative complications. The results showed no significant difference in complications or surgical success rate between the two treatments, but total neoadjuvant therapy patients had longer operative times, greater blood loss, and lower lymph node yield.

DISEASES OF THE COLON & RECTUM (2023)

Article Oncology

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Julio Garcia-Aguilar et al.

Summary: This study demonstrates that organ preservation is achievable in patients with locally advanced rectal cancer treated with total neoadjuvant therapy, without a decrease in survival.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Oncology

Watch and wait: Why, to whom and how

Carlos Cerdan-Santacruz et al.

Summary: The current standard of care for locally advanced rectal cancer includes neoadjuvant chemo-radiation followed by total mesorectal excision. However, the watch and wait strategy (W&W), which involves close surveillance without immediate surgery, has become an attractive alternative in selected patients who achieve complete tumor regression. This approach offers the potential benefits of avoiding radical surgery, but the risk of local tumor regrowth must be carefully considered. This article explores the advantages and disadvantages of W&W and highlights the key issues related to staging, treatment regimens, and tumor response assessment that need to be addressed for successful implementation of this strategy. In the context of contemporary neoadjuvant treatment regimens, achieving a clinical complete response is likely to impact a significant proportion of patients, and with evolving imaging technologies, W&W is expected to become an integral part of multidisciplinary management decisions.

SURGICAL ONCOLOGY-OXFORD (2022)

Review Oncology

Non-Operative Management of Patients with Rectal Cancer: Lessons Learnt from the OPRA Trial

Paolo Goffredo et al.

Summary: The management of rectal cancer has become more complex, with chemotherapy and radiation before surgery being accepted as a new standard. Watch and wait and non-operative management are potential treatment options, but identifying suitable candidates remains challenging.

CANCERS (2022)

Article Surgery

Effect of interval between neoadjuvant chemoradiotherapy and surgery on disease recurrence and survival in rectal cancer: long-term results of a randomized clinical trial

Erhan Akgun et al.

Summary: The optimal timing of surgery following chemoradiotherapy (CRT) for locally advanced rectal adenocarcinoma (LARC) remains controversial. This study found that an interval of more than 8 weeks between CRT and surgery decreased the incidence of distant metastasis, but did not affect disease-free survival (DFS) or overall survival (OS).

BJS OPEN (2022)

Article Oncology

Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer

Asif Mehraj et al.

Summary: Older age, longer interval between NACRT and surgery, node-negative disease, and favorable tumor grade have been identified as strong predictors of pathological complete response (pCR) in locally advanced rectal cancer (LARC) patients undergoing NACRT.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2022)

Article Oncology

BRIDGE-1 TRIAL: BReak Interval Delayed surgery for Gastrointestinal Extraperitoneal rectal cancer, a multicentric phase III randomized trial

Giuditta Chiloiro et al.

Summary: This study aims to investigate the impact of lengthening the interval between neoadjuvant chemoradiotherapy (nCRT) and surgery on the treatment outcomes and quality of life of patients with locally advanced rectal cancer. The results of this study may provide a new time frame for the clinical re-evaluation of complete/major responders, leading to increased treatment success for nCRT.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2022)

Review Gastroenterology & Hepatology

Does a long interval between neoadjuvant chemoradiotherapy and surgery benefit the clinical outcomes of locally advanced rectal cancer? A systematic review and meta analyses

Miao Yu et al.

Summary: The study systematically evaluated the clinical efficacy of a long interval (8 weeks) between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer. The results showed that a longer interval improved the pathologic complete response rate but had no significant impact on clinical efficacy or long-term prognosis.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2022)

Article Oncology

Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials

Maria Antonietta Gambacorta et al.

Summary: The optimal timing of surgery after neoadjuvant chemoradiotherapy for locally advanced rectal cancer remains controversial. A study found that lengthening the surgical interval had a favorable impact on achieving a pathological complete response, with the best results seen at a 10-week interval.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Surgery

Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation

Simona Deidda et al.

Summary: In this study, a longer interval between completion of neoadjuvant CRT and surgery was found to be associated with poorer overall and disease-free survival in patients with poor tumor response. This suggests that surgery should not be delayed for patients with a poor response to CRT.

JAMA SURGERY (2021)

Article Oncology

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy et al.

Summary: In patients with cT3 or cT4 M0 rectal cancer, intensifying chemotherapy with FOLFIRINOX before preoperative chemoradiotherapy significantly improved disease-free survival outcomes and reduced neurotoxicity. Thus, the PRODIGE 23 results have the potential to impact clinical practice.

LANCET ONCOLOGY (2021)

Review Gastroenterology & Hepatology

Watch and wait approach in rectal cancer: Current controversies and future directions

Fernando Lopez-Campos et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients

Shi-Wen Mei et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation

Patricio B. Lynn et al.

CLINICS IN COLON AND RECTAL SURGERY (2017)

Article Oncology

Neoadjuvant Chemotherapy First, Followed by Chemoradiation and Then Surgery, in the Management of Locally Advanced Rectal Cancer

Andrea Cercek et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)

Article Surgery

Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer

D. A. M. Sloothaak et al.

BRITISH JOURNAL OF SURGERY (2013)

Review Oncology

Wound healing after radiation therapy: Review of the literature

Frank Haubner et al.

RADIATION ONCOLOGY (2012)

Review Gastroenterology & Hepatology

Sexual Function After Treatment for Rectal Cancer: A Review

Vanessa P. Ho et al.

DISEASES OF THE COLON & RECTUM (2011)

Review Surgery

Postoperative Complications Following Surgery for Rectal Cancer

Bogdan C. Paun et al.

ANNALS OF SURGERY (2010)